The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
Open accessAbstract
Iron oxide nanoparticles with unique magnetic properties have a high potential for use in several biomedical, bioengineering and in vivo applications, including tissue repair, magnetic resonance imaging, immunoassay, drug delivery, detoxification of biologic fluids, cell sorting, and hyperthermia. Although various surface modifications are being done for making these nonbiodegradable nanoparticles more biocompatible, their toxic potential is still a major concern. The current in vitro study of the interaction of superparamagnetic iron oxide nanoparticles of mean diameter 30 nm coated with Tween 80 and murine macrophage (J774) cells was undertaken to evaluate the dose- and time-dependent toxic potential, as well as investigate the role of oxidative stress in the toxicity. A 15-30 nm size range of spherical nanoparticles were characterized by transmission electron microscopy and zeta sizer. MTT assay showed >95% viability of cells in lower concentrations (25-200 μg/mL) and up to three hours of exposure, whereas at higher concentrations (300-500 μg/mL) and prolonged (six hours) exposure viability reduced to 55%-65%. Necrosis-apoptosis assay by propidium iodide and Hoechst-33342 staining revealed loss of the majority of the cells by apoptosis. H₂DCFDDA assay to quantify generation of intracellular reactive oxygen species (ROS) indicated that exposure to a higher concentration of nanoparticles resulted in enhanced ROS generation, leading to cell injury and death. The cell membrane injury induced by nanoparticles studied using the lactate dehydrogenase assay, showed both concentration- and time-dependent damage. Thus, this study concluded that use of a low optimum concentration of superparamagnetic iron oxide nanoparticles is important for avoidance of oxidative stress-induced cell injury and death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Magnetic nanoparticles in MR imaging and drug delivery
Sun, C., Lee, J. S. H., & Zhang, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.018 · Cited by 2,594
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake
Zhang, Y., Kohler, N., & Zhang, M. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00267-8 · Cited by 1,264
The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome
Zhang, J., Bottiglieri, T., & McCullough, P. A. (2017) · Cardiorenal Medicine · doi:10.1159/000452283 · Cited by 1,080
Locoregional cancer treatment with magnetic drug targeting.
Alexiou, C., Arnold, W. J., Klein, R. J., Parak, F., Hulin, P., Bergemann, C., Erhardt, W. D., Wagenpfeil, S., & Lübbe, A. S. (2000) · PubMed · Cited by 863
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Clinical Applications of Magnetic Drug Targeting
Lübbe, A. S., Alexiou, C., & Bergemann, C. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2000.6030 · Cited by 844
Oxidant stress and endothelial cell dysfunction
Lum, H., & Roebuck, K. A. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c719 · Cited by 832
Lübbe, A. S., Bergemann, C., Riess, H. B., Schriever, F., Reichardt, P., Possinger, K., Matthias, M., Dörken, B., Herrmann, F., Gürtler, R., et al. (1996) · PubMed · Cited by 652
Kohler, N., Sun, C., Wang, J., & Zhang, M. (2005) · Langmuir · doi:10.1021/la0503451 · Cited by 579
Nanoparticles: Health Effects—Pros and Cons
Gwinn, M. R., & Vallyathan, V. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8871 · Cited by 571
Preparation and application of magnetic Fe3O4 nanoparticles for wastewater purification
Shen, Y. F., Tang, J., Nie, Z. H., Wang, Y. D., Ren, Y., & Zuo, L. (2009) · Separation and Purification Technology · doi:10.1016/j.seppur.2009.05.020 · Cited by 570
Synthesis of Iron Oxide Nanoparticles Used as MRI Contrast Agents: A Parametric Study
Babes, L., Denizot, B., Tanguy, G., Le Jeune, J. J., & Jallet, P. (1999) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1998.6053 · Cited by 567
Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro
Berry, C. C., Wells, S., Charles, S., & Curtis, A. S. G. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00237-0 · Cited by 524
Sonvico, F., Mornet, S., Vasseur, S., Dubernet, C., Jaillard, D., Degrouard, J., Hoebeke, J., Duguet, E., Colombo, P., & Couvreur, P. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050050z · Cited by 484
Magnetic Clusters in Molecular Beams, Metals, and Semiconductors
Shi, J., Gider, S., Babcock, K., & Awschalom, D. D. (1996) · Science · doi:10.1126/science.271.5251.937 · Cited by 465
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Dong, S. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2824 · Cited by 464
Apopa, P. L., Qian, Y., Shao, R., Guo, N. L., Schwegler-Berry, D., Pacurari, M., Porter, D., Shi, X., Vallyathan, V., Castranova, V., et al. (2009) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-6-1 · Cited by 445
Raynal, I., Prigent, P., Peyramaure, S., Najid, A., Rebuzzi, C., & Corot, C. (2004) · Investigative Radiology · doi:10.1097/01.rli.0000101027.57021.28 · Cited by 403
Gupta, A. K., & Curtis, A. S. G. (2004) · Journal of Materials Science: Materials in Medicine · doi:10.1023/b:jmsm.0000021126.32934.20 · Cited by 402
Yang, J., Lee, C., Ko, H., Suh, J., Yoon, H., Lee, K., Huh, Y., & Haam, S. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200703554 · Cited by 331
Cell response to dextran-derivatised iron oxide nanoparticles post internalisation
Berry, C. C., Wells, S., Charles, S., Aitchison, G., & Curtis, A. S. G. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.12.046 · Cited by 313
Magnetic targeting for site-specific drug delivery: applications and clinical potential
Polyak, B., & Friedman, G. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802662795 · Cited by 260
Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolism
Pouliquen, D., Le Jeune, J. J., Perdrisot, R., Ermias, A., & Jallet, P. (1991) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(91)90412-f · Cited by 222
Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures
Cengelli, F., Maysinger, D., Tschudi-Monnet, F., Montet, X., Corot, C., Petri-Fink, A., Hofmann, H., & Juillerat-Jeanneret, L. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101915 · Cited by 177
Monodisperse magnetic nanoparticles for biomedical applications
Xu, C., & Sun, S. (2007) · Polymer International · doi:10.1002/pi.2251 · Cited by 171
Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC)
Rudge, S. R., Peterson, C., Vessely, C., Koda, J. E., Stevens, S., & Catterall, L. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00344-3 · Cited by 139
MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents
Funovics, M. A., Kapeller, B., Höeller, C., Su, H. S., Kunstfeld, R., Puig, S., & Macfelda, K. (2004) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2004.01.050 · Cited by 138
Schütt, W., Grüttner, C., Häfeli, U. O., Zborowski, M., Teller, J., Putzar, H., & Schümichen, C. (1997) · Hybridoma · doi:10.1089/hyb.1997.16.109 · Cited by 109
Zhang, Y., Sun, C., Kohler, N., & Zhang, M. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000013363.77466.63 · Cited by 105
Design strategies to improve soluble macromolecular delivery constructs
Christie, R. J., & Grainger, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00229-6 · Cited by 103
Biological effects of magnetic fluids: toxicity studies
Lacava, Z. G. M., Azevedo, R. B., Martins, E., Lacava, L. M., Freitas, M. L. L., Garcia, V. A. P., Rébula, C. A., Lemos, A. P. C., Sousa, M. H., Tourinho, F. A., et al. (1999) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(99)00002-5 · Cited by 93
Meng, J., Fan, J., Galiana, G., Branca, R. T., Clasen, P. L., Ma, S., Zhou, J., Leuschner, C., Kumar, C. S. S. R., Hormes, J., et al. (2008) · Materials Science and Engineering C · doi:10.1016/j.msec.2008.09.039 · Cited by 92
Song, M., Moon, W. K., Kim, Y., Lim, D., Song, I. C., & Yoon, B. (2007) · Korean Journal of Radiology · doi:10.3348/kjr.2007.8.5.365 · Cited by 74
Yang, J., Lee, C., Ko, H. J., Suh, J., Yoon, H., Lee, K., Huh, Y., & Haam, S. (2007) · Angewandte Chemie · doi:10.1002/ange.200703554 · Cited by 47
Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy
Peng, X., Chen, H., Huang, J., Mao, H. Z., & Dong, M.-J. (2011) · InTech eBooks · doi:10.5772/22873 · Cited by 39
Ström, V., Hultenby, K. R., Grüttner, C., Teller, J., Xu, B., & Holgersson, J. (2004) · Nanotechnology · doi:10.1088/0957-4484/15/5/009 · Cited by 32
Adverse Drug Events Related to Dosage Forms and Delivery Systems
Uchegbu, I. F., & Florence, A. T. (1996) · Drug Safety · doi:10.2165/00002018-199614010-00005 · Cited by 28
Biocompatible Magnetic Polymer Carriers for In Vivo Radionuclide Delivery
Schütt, W., Grüttner, C., Teller, J., Westphal, F., Häfeli, U. O., Paulke, B., Goetz, P., & Finck, W. (1999) · Artificial Organs · doi:10.1046/j.1525-1594.1999.06278.x · Cited by 28
Morphine-Induced Degradation of the Host Defense Barrier
Frenklakh, L., Bhat, R. S., Bhaskaran, M. C., Sharma, S., Sharma, M., Dinda, A. K., & Singhal, P. C. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3132-0 · Cited by 23
Self-citation
Cited by
Mechanisms of Nanoparticle-Induced Oxidative Stress and Toxicity
Manke, A., Wang, L., & Rojanasakul, Y. (2013) · BioMed Research International · doi:10.1155/2013/942916 · Cited by 1,727
Nanoparticles as drug delivery systems
Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445
Biological applications of magnetic nanoparticles
Colombo, M., Carregal-Romero, S., Casula, M. F., Gutiérrez, L., Morales, M. P., Böhm, I. B., Heverhagen, J. T., Prosperi, D., & Parak, W. J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15337h · Cited by 1,315
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
Chen, Z., Yin, J.-J., Zhou, Y.-T., Zhang, Y., Song, L., Song, M., Hu, S., & Gu, N. (2012) · ACS Nano · doi:10.1021/nn300291r · Cited by 940
Metadata
- Authors
- Naqvi, Naqvi, Samim, M., Abdin, M. Z., Ahmad, F. J., prashant, C. K., & Dinda, A.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2010-11
- Volume
- 5
- Pages
- 983
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W1855443516
- Cited by
- 474
- References
- 41
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.